Avantor (AVTR) Income from Continuing Operations (2018 - 2026)
Avantor's (AVTR) quarterly Income from Continuing Operations came in at 43300000.0 in Q1 2026, down 32.87% year-on-year from 64500000.0 in Q1 2025, and down 17.37% quarter-over-quarter from 52400000.0 in Q4 2025.
Avantor (AVTR) Income from Continuing Operations (2018 - 2026) Analysis & Trends
Avantor's Income from Continuing Operations history runs 9 years deep, the most recent figure standing at 43300000.0 for Q1 2026.
- On a quarterly basis, Income from Continuing Operations fell 32.87% year-over-year to 43300000.0 in Q1 2026; TTM through Mar 2026 was 551400000.0, a 177.05% decrease from a year earlier, with the FY2025 full-year figure at 530200000.0, down 174.52% from the prior year.
- Income from Continuing Operations eased to 43300000.0 in Q1 2026 per AVTR's latest filing, from 52400000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 500400000.0 in Q4 2024 and bottomed at 711800000.0 in Q3 2025.
- The 5-year median for Income from Continuing Operations is 92900000.0 (2024), against an average of 72482352.94.
- Across the five-year window, Income from Continuing Operations surged 1372.6% in 2024 and plunged 1331.49% in 2025, its largest moves.
- Year by year, Income from Continuing Operations stood at 141700000.0 in 2022, then sank by 30.49% to 98500000.0 in 2023, then surged by 408.02% to 500400000.0 in 2024, then plunged by 89.53% to 52400000.0 in 2025, then retreated by 17.37% to 43300000.0 in 2026.
- Per Business Quant, the three latest AVTR Income from Continuing Operations figures stand at 43300000.0 (Q1 2026), 52400000.0 (Q4 2025), and 711800000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 240.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -37.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 13.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Avantor | 7.67 Bn | 7.39 Bn | 500.70 Mn | 43.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 43.30 Mn |
| Dec 31, 2025 | 52.40 Mn |
| Sep 30, 2025 | -711.80 Mn |
| Jun 30, 2025 | 64.70 Mn |
| Mar 31, 2025 | 64.50 Mn |
| Dec 31, 2024 | 500.40 Mn |
| Sep 30, 2024 | 57.80 Mn |
| Jun 30, 2024 | 92.90 Mn |
| Mar 31, 2024 | 60.40 Mn |
| Dec 31, 2023 | 98.50 Mn |
| Sep 30, 2023 | 108.40 Mn |
| Jun 30, 2023 | -7.30 Mn |
| Mar 31, 2023 | 121.50 Mn |
| Dec 31, 2022 | 141.70 Mn |
| Sep 30, 2022 | 167.00 Mn |
| Jun 30, 2022 | 187.40 Mn |
| Mar 31, 2022 | 190.40 Mn |
| Dec 31, 2021 | 94.00 Mn |
| Sep 30, 2021 | 156.80 Mn |
| Jun 30, 2021 | 157.80 Mn |